THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 106 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 2.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164 | -35.4% | 18,994 | -22.5% | 0.00% | – |
| Q2 2023 | $254 | -30.4% | 24,506 | -27.2% | 0.00% | – |
| Q1 2023 | $365 | -25.5% | 33,671 | -22.9% | 0.00% | -100.0% |
| Q4 2022 | $490 | -99.9% | 43,654 | -0.0% | 0.00% | 0.0% |
| Q3 2022 | $443,000 | +12.4% | 43,659 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $394,000 | +15.2% | 43,518 | +21.5% | 0.00% | – |
| Q1 2022 | $342,000 | -13.6% | 35,817 | +0.0% | 0.00% | – |
| Q4 2021 | $396,000 | +85.0% | 35,806 | +23.7% | 0.00% | – |
| Q3 2021 | $214,000 | -69.1% | 28,951 | -39.3% | 0.00% | -100.0% |
| Q2 2021 | $693,000 | -18.0% | 47,694 | +15.2% | 0.00% | 0.0% |
| Q1 2021 | $845,000 | +14.8% | 41,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $736,000 | +20.3% | 41,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $612,000 | -29.6% | 41,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $869,000 | -10.9% | 41,400 | -1.9% | 0.00% | 0.0% |
| Q1 2020 | $975,000 | -10.8% | 42,200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,093,000 | +16.6% | 42,200 | -12.3% | 0.00% | 0.0% |
| Q3 2019 | $937,000 | +36.4% | 48,100 | +14.3% | 0.00% | 0.0% |
| Q2 2019 | $687,000 | -28.0% | 42,100 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $954,000 | -11.4% | 42,100 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $1,077,000 | -28.8% | 42,100 | -9.1% | 0.00% | 0.0% |
| Q3 2018 | $1,513,000 | +44.1% | 46,300 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $1,050,000 | -6.5% | 46,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,123,000 | -13.0% | 46,300 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $1,291,000 | -18.5% | 46,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,585,000 | -14.1% | 46,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,845,000 | +18.2% | 46,300 | +9.2% | 0.00% | 0.0% |
| Q1 2017 | $1,561,000 | +28.2% | 42,401 | +11.0% | 0.00% | 0.0% |
| Q4 2016 | $1,218,000 | -12.0% | 38,200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,384,000 | +120.0% | 38,200 | +37.9% | 0.00% | +100.0% |
| Q2 2016 | $629,000 | +20.7% | 27,700 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $521,000 | +36.4% | 27,700 | +18.9% | 0.00% | 0.0% |
| Q4 2015 | $382,000 | +49.2% | 23,300 | 0.0% | 0.00% | – |
| Q3 2015 | $256,000 | -26.6% | 23,300 | -13.2% | 0.00% | -100.0% |
| Q2 2015 | $349,000 | – | 26,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |